Saturday 24 January 2026
Home      All news      Contact us      RSS     
Yale - 17 days ago

How novel anti-obesity drugs are changing the trajectory of cardiometabolic disease

At Yale School of Medicine, researchers are studying the impact of GLP-1 agonists on cardiometabolic diseases and beyond. They are also exploring the next treatments in the pipeline that could build further on the life-changing benefits the drugs offer.


Latest News
Hashtags:   

novel

 | 

obesity

 | 

drugs

 | 

changing

 | 

trajectory

 | 

cardiometabolic

 | 

disease

 | 

Sources